In cancer, the binding between CXCL12 and its receptors causes different pathways activation, that, through cancer cells, migration, angiogenesis, and epithelial to mesenchymal transition (EMT) [39], are involved in tumor initiation and progression [36, 40]. The gene discussed is CXCL12; the disease is neoplasm.